107.42
price down icon1.10%   -1.19
after-market After Hours: 106.81 -0.61 -0.57%
loading
Abbott Laboratories stock is traded at $107.42, with a volume of 21.77M. It is down -1.10% in the last 24 hours and down -13.75% over the past month. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
See More
Previous Close:
$108.61
Open:
$108.27
24h Volume:
21.77M
Relative Volume:
3.13
Market Cap:
$186.79B
Revenue:
$43.84B
Net Income/Loss:
$13.90B
P/E Ratio:
13.47
EPS:
7.9725
Net Cash Flow:
$6.92B
1W Performance:
-11.78%
1M Performance:
-13.75%
6M Performance:
-14.63%
1Y Performance:
-12.82%
1-Day Range:
Value
$106.08
$110.05
1-Week Range:
Value
$105.78
$122.49
52-Week Range:
Value
$105.78
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
Name
Abbott Laboratories
Name
Phone
(224) 667-6100
Name
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Employee
114,000
Name
Twitter
@AbbottNews
Name
Next Earnings Date
2026-01-22
Name
Latest SEC Filings
Name
ABT's Discussions on Twitter

Compare ABT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
ABT
Abbott Laboratories
107.42 188.86B 43.84B 13.90B 6.92B 7.9725
Medical Devices icon
BSX
Boston Scientific Corp
92.51 135.38B 19.35B 2.78B 3.82B 1.8696
Medical Devices icon
SYK
Stryker Corp
355.04 137.16B 24.38B 2.94B 4.07B 7.6159
Medical Devices icon
MDT
Medtronic Plc
100.88 129.92B 34.76B 4.79B 5.21B 3.7017
Medical Devices icon
EW
Edwards Lifesciences Corp
83.66 49.00B 5.88B 1.34B 799.60M 2.3489

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-10-25 Initiated The Benchmark Company Buy
Jul-18-25 Upgrade Jefferies Hold → Buy
Jun-16-25 Initiated Leerink Partners Market Perform
Oct-08-24 Initiated Oppenheimer Outperform
Sep-19-24 Initiated Piper Sandler Overweight
Jul-30-24 Downgrade Edward Jones Buy → Hold
May-30-24 Initiated Goldman Buy
Jul-21-23 Upgrade Wolfe Research Underperform → Peer Perform
May-30-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-20-23 Reiterated Barclays Overweight
Apr-20-23 Reiterated Bernstein Outperform
Apr-20-23 Reiterated JP Morgan Overweight
Apr-20-23 Reiterated Raymond James Outperform
Apr-20-23 Reiterated UBS Buy
Apr-20-23 Reiterated Wolfe Research Underperform
Mar-29-23 Initiated UBS Buy
Oct-26-22 Initiated Mizuho Neutral
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Hold
Jul-06-22 Initiated Wolfe Research Underperform
Mar-02-22 Resumed BofA Securities Buy
Jan-27-22 Reiterated Credit Suisse Outperform
Jan-27-22 Reiterated Morgan Stanley Overweight
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated UBS Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Oct-27-21 Upgrade Atlantic Equities Neutral → Overweight
Oct-14-21 Initiated Redburn Neutral
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Jan-28-21 Upgrade BTIG Research Neutral → Buy
Sep-11-20 Initiated Wolfe Research Outperform
Jun-01-20 Downgrade Goldman Neutral → Sell
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-02-20 Downgrade Guggenheim Buy → Neutral
Jun-13-19 Reiterated BofA/Merrill Buy
Feb-07-19 Reiterated BofA/Merrill Buy
Jan-02-19 Downgrade Citigroup Neutral → Sell
Nov-30-18 Upgrade Goldman Neutral → Buy
Oct-16-18 Initiated Barclays Overweight
Jun-27-18 Initiated Bernstein Outperform
Jan-30-18 Reiterated Citigroup Neutral
Jan-25-18 Reiterated Stifel Buy
Jan-25-18 Upgrade William Blair Mkt Perform → Outperform
Jan-03-18 Initiated Evercore ISI Outperform
Jan-02-18 Upgrade JP Morgan Neutral → Overweight
Jan-02-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-19-17 Reiterated RBC Capital Mkts Outperform
Oct-19-17 Reiterated Stifel Buy
View All

Abbott Laboratories Stock (ABT) Latest News

pulisher
03:06 AM

Citigroup Cuts Abbott Laboratories (NYSE:ABT) Price Target to $140.00 - MarketBeat

03:06 AM
pulisher
12:59 PM

Abbott's India Unit Under Scrutiny Due To Phensedyl Cough Syrup Supply Chain - Benzinga

12:59 PM
pulisher
11:22 AM

Tesla To $360? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

11:22 AM
pulisher
11:12 AM

Sanford C. Bernstein Lowers Abbott Laboratories (NYSE:ABT) Price Target to $125.00 - MarketBeat

11:12 AM
pulisher
11:01 AM

UBS reiterates Buy rating on Abbott Labs stock with $158 price target - Investing.com

11:01 AM
pulisher
11:00 AM

Abbott Laboratories Analyst Cuts Price Target After Q4 Miss, Expects Sales Growth To Accelerate In H2 - Benzinga

11:00 AM
pulisher
10:34 AM

Abbott Laboratories (NYSE:ABT) Given New $130.00 Price Target at Raymond James Financial - MarketBeat

10:34 AM
pulisher
10:34 AM

Abbott Laboratories (NYSE:ABT) Price Target Cut to $132.00 by Analysts at Oppenheimer - MarketBeat

10:34 AM
pulisher
10:34 AM

The Goldman Sachs Group Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat

10:34 AM
pulisher
10:34 AM

Abbott Laboratories (NYSE:ABT) Price Target Lowered to $135.00 at Royal Bank Of Canada - MarketBeat

10:34 AM
pulisher
09:54 AM

Oppenheimer Adjusts Price Target for Abbott Laboratories (ABT) | - GuruFocus

09:54 AM
pulisher
09:37 AM

Abbott Labs stock price target lowered to $125 by Bernstein SocGen - Investing.com

09:37 AM
pulisher
09:36 AM

Evercore ISI Issues Pessimistic Forecast for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat

09:36 AM
pulisher
09:26 AM

Is The Fall In Abbott Stock Justified? - Forbes

09:26 AM
pulisher
09:11 AM

Piper Sandler Lowers Price Target for Abbott Laboratories (ABT) - GuruFocus

09:11 AM
pulisher
09:04 AM

Abbott Labs stock price target lowered to $135 by RBC Capital By Investing.com - Investing.com Nigeria

09:04 AM
pulisher
09:03 AM

TD Cowen lowers Abbott Labs stock price target on Q4 revenue miss - Investing.com

09:03 AM
pulisher
08:51 AM

Teacher Retirement System of Texas Sells 122,066 Shares of Abbott Laboratories $ABT - MarketBeat

08:51 AM
pulisher
08:41 AM

How Did Abbott Fare In Q4 And What Lies Ahead? - Trefis

08:41 AM
pulisher
08:39 AM

Piper Sandler Issues Pessimistic Forecast for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat

08:39 AM
pulisher
08:37 AM

Benchmark reiterates Buy rating on Abbott Labs stock amid tepid Q4 - Investing.com

08:37 AM
pulisher
08:37 AM

Abbott Labs stock price target lowered to $135 by RBC Capital - Investing.com

08:37 AM
pulisher
08:24 AM

Abbott faces India scrutiny in cough syrup abuse investigation, documents show - Reuters

08:24 AM
pulisher
08:20 AM

Abbott Laboratories (NYSE:ABT) Q4 2025 earnings call transcript - MSN

08:20 AM
pulisher
08:16 AM

Piper Sandler lowers Abbott Labs stock price target on nutrition segment weakness - Investing.com

08:16 AM
pulisher
08:08 AM

Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript - Insider Monkey

08:08 AM
pulisher
08:05 AM

Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings - Fierce Biotech

08:05 AM
pulisher
07:39 AM

Abbott Labs stock price target lowered to $122 by Wells Fargo on nutrition headwinds - Investing.com

07:39 AM
pulisher
07:25 AM

Abbott Laboratories: Buy This Dividend King On Sale Now (NYSE:ABT) - Seeking Alpha

07:25 AM
pulisher
07:19 AM

Abbott Labs stock price target lowered to $132 at Oppenheimer on Q4 results - Investing.com Australia

07:19 AM
pulisher
07:17 AM

Abbott Labs stock price target lowered to $145 by Jefferies on nutrition segment miss - Investing.com Nigeria

07:17 AM
pulisher
07:09 AM

Strs Ohio Sells 35,951 Shares of Abbott Laboratories $ABT - MarketBeat

07:09 AM
pulisher
06:40 AM

Simplicity Wealth LLC Has $2.22 Million Position in Abbott Laboratories $ABT - MarketBeat

06:40 AM
pulisher
06:40 AM

Abbott Labs stock price target lowered to $130 by Raymond James - Investing.com

06:40 AM
pulisher
05:24 AM

Abbott stock sank 10% on earnings — what traders watch before the bell - TechStock²

05:24 AM
pulisher
04:29 AM

Abbott Labs (ABT) Stock Tumbles 8% as Weak Nutrition Sales Offset Strong Device Growth - CoinCentral

04:29 AM
pulisher
02:22 AM

Abbott Stock Suffers Worst Drop In More Than 20 Years - Eudaimonia and Co

02:22 AM
pulisher
12:54 PM

Abbott Laboratories Share Price Falls 8% After Revenue Miss | Stock Market Today - Samco

12:54 PM
pulisher
12:33 PM

ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook - FinancialContent

12:33 PM
pulisher
Jan 22, 2026

Abbott Stock Suffers Worst Drop in More Than 20 Years - The Wall Street Journal

Jan 22, 2026
pulisher
Jan 22, 2026

Abbott has mixed Q4 results, but medtech sales up 12.3% - MassDevice

Jan 22, 2026
pulisher
Jan 22, 2026

Abbott Laboratories Earnings Call: Devices Offset Nutrition Drag - TipRanks

Jan 22, 2026
pulisher
Jan 22, 2026

Traders Purchase High Volume of Put Options on Abbott Laboratories (NYSE:ABT) - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Abbott misses Q4 expectations - BioWorld MedTech

Jan 22, 2026
pulisher
Jan 22, 2026

Stock Movers: Carvana, Abbott, Intel - Bloomberg.com

Jan 22, 2026
pulisher
Jan 22, 2026

Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness - The Chronicle-Journal

Jan 22, 2026
pulisher
Jan 22, 2026

Intel, GE Aerospace, Moderna, Abbott, Mobileye, McCormick, and More Stock Movers - Barron's

Jan 22, 2026
pulisher
Jan 22, 2026

Earnings live: GE Aerospace orders surge, Procter & Gamble stock rises, Abbott tumbles - Yahoo Finance

Jan 22, 2026
pulisher
Jan 22, 2026

Abbott Falls Short in 4th Quarter Earnings - Medical Device and Diagnostic industry

Jan 22, 2026
pulisher
Jan 22, 2026

Abbott Laboratories stock underperforms Thursday when compared to competitors - MarketWatch

Jan 22, 2026
pulisher
Jan 22, 2026

Abbott Laboratories (ABT) Q4 2025 Earnings Call Highlights: Navi - GuruFocus

Jan 22, 2026

Abbott Laboratories Stock (ABT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices BSX
$92.51
price up icon 1.34%
medical_devices SYK
$355.04
price down icon 1.01%
medical_devices MDT
$100.88
price down icon 0.45%
medical_devices EW
$83.66
price down icon 0.92%
$79.77
price down icon 2.59%
Cap:     |  Volume (24h):